FDA considers psychedelic MDMA therapy for post-traumatic stress disorderDescription: A panel of advisors to the FDA on Tuesday will weigh whether the agency should approve the use of MDMA, also known as ecstasy, to treat post-traumatic stress disorder. CNN’s Chief Medical Correspondent Sanjay Gupta reports.
Must Read
At UW’s D Center, Students Find Community, Rest, And Representation
The Disability and Deaf Cultural Center (D Center) at the University of Washington provides a safe, inclusive space for students, staff, and faculty to learn, socialize, and celebrate pride in community, while also offering resources such as a low-sensory chill space and a sensory space for relaxation.
